granulomatosis with polyangiitis
granulomatosis with polyangiitis
Explore linked clinical trials. Standard reference: MONDO:001210521 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis | Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, cardiovascular disorder, granulomatosis with polyangiitis, immune system disorder, interstitial lung disease, lung disorder, necrotizing vasculitis, respiratory system disorder, skin disorder, skin vascular disease, vascular disorder, vasculitis | Active, not recruiting | Phase 1 / Phase 2 | 2026-09-25 | NCT03919435 | |
| Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA | Cerebral Small Vessel Diseases, Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, granulomatosis with polyangiitis, immune system disorder, interstitial lung disease, lung disorder, microscopic polyangiitis, necrotizing vasculitis, nervous system disorder, respiratory system disorder, skin disorder, skin vascular disease, vascular disorder, vasculitis | Active, not recruiting | Phase 2 | 2026-09-04 | NCT06868290 | |
| TAVNEOS for Otolaryngologic Manifestations of Granulomatosis With Polyangiitis | Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, cardiovascular disorder, granulomatosis with polyangiitis, immune system disorder, interstitial lung disease, lung disorder, necrotizing vasculitis, respiratory system disorder, skin disorder, skin vascular disease, vascular disorder, vasculitis | Recruiting | Phase 2 / Phase 3 | 2026-09-02 | NCT07176546 | |
| Iptacopan in Patients With ANCA Associated Vasculitis | Cerebral Small Vessel Diseases, Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, granulomatosis with polyangiitis, immune system disorder, interstitial lung disease, lung disorder, microscopic polyangiitis, necrotizing vasculitis, nervous system disorder, respiratory system disorder, skin disorder, skin vascular disease, vascular disorder, vasculitis | Active, not recruiting | Phase 2 | 2026-08-20 | NCT06388941 | |
| Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases | Aortic Arch Syndromes, Axial Spondyloarthritis, Cerebral Small Vessel Diseases, Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, Spondylarthritis, Spondylarthropathies, Takayasu arteritis, ankylosis, anti-neutrophil cytoplasmic antibody-associated vasculitis, antiphospholipid syndrome, aortic disorder, arteritis, arthritic joint disease, arthropathy, autoimmune disease, bone disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, connective tissue disorder, granulomatosis with polyangiitis, immune system disorder, interstitial lung disease, juvenile idiopathic arthritis, lung disorder, microscopic polyangiitis, muscle tissue disorder, musculoskeletal system disorder, myositis disease, necrotizing vasculitis, nervous system disorder, neuromuscular disease, psoriasis, psoriatic arthritis, respiratory system disorder, rheumatic disorder, rheumatoid arthritis, skin disorder, skin vascular disease, spondylitis, systemic lupus erythematosus, systemic sclerosis, vascular disorder, vasculitis, vertebral column disorder | Recruiting | Phase 4 | 2026-07-20 | NCT07087912 | |
| Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty | Axial Spondyloarthritis, Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, Spondylarthritis, Spondylarthropathies, ankylosing spondylitis, ankylosis, anti-neutrophil cytoplasmic antibody-associated vasculitis, arteritis, arthritic joint disease, arthropathy, autoimmune disease, autoimmune disorder of the nervous system, bone disorder, brain disorder, cardiovascular disorder, central nervous system disorder, central nervous system vasculitis, cerebrovascular disorder, connective tissue disorder, dermatomyositis, granulomatosis with polyangiitis, immune system disorder, interstitial lung disease, juvenile idiopathic arthritis, lung disorder, muscle tissue disorder, musculoskeletal system disorder, myositis disease, necrotizing vasculitis, nervous system disorder, neuromuscular disease, polymyalgia rheumatica, polymyositis, psoriasis, psoriatic arthritis, respiratory system disorder, rheumatic disorder, rheumatoid arthritis, skin disorder, skin vascular disease, spondylitis, systemic lupus erythematosus, temporal arteritis, vascular disorder, vasculitis, vertebral column disorder | Recruiting | Phase 2 | 2026-07-09 | NCT07138898 | |
| Ocular Manifestations of Granulomatosis With Polyangiitis. | Cerebral Small Vessel Diseases, Granuloma, Hemic and Lymphatic Diseases, Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, eosinophilic granulomatosis with polyangiitis, granulomatosis with polyangiitis, immune system disorder, lymphatic system disorder, lymphoproliferative syndrome, microscopic polyangiitis, necrotizing vasculitis, nervous system disorder, skin disorder, skin vascular disease, vascular disorder, vasculitis | Recruiting | Not stated | 2026-06-24 | NCT07664709 | |
| Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis | Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, cardiovascular disorder, granulomatosis with polyangiitis, immune system disorder, interstitial lung disease, lung disorder, necrotizing vasculitis, respiratory system disorder, skin disorder, skin vascular disease, vascular disorder, vasculitis | Recruiting | Phase 3 | 2026-04-03 | NCT04871191 | |
| Obinutuzumab for Remission Induction in Patients With Relapsing PR3-ANCA Granulomatosis With Polyangiitis | Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, cardiovascular disorder, granulomatosis with polyangiitis, immune system disorder, interstitial lung disease, lung disorder, necrotizing vasculitis, respiratory system disorder, skin disorder, skin vascular disease, vascular disorder, vasculitis | Recruiting | Phase 2 | 2026-03-06 | NCT06940661 | |
| Comparison of a Strategy Based on Clinico-biological Monitoring Versus Pre-emptive Rituximab Treatment in Cases of ANCA Reappearance in Granulomatosis With Polyangiitis and Microscopic Polyangiitis. | Cerebral Small Vessel Diseases, Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, granulomatosis with polyangiitis, immune system disorder, interstitial lung disease, lung disorder, microscopic polyangiitis, necrotizing vasculitis, nervous system disorder, respiratory system disorder, skin disorder, skin vascular disease, vascular disorder, vasculitis | Not yet recruiting | Phase 4 | 2026-03-05 | NCT07451847 | |
| Safe Effective Therapy With Low-Dose Glucocorticoid in ANCA-Associated Vasculitis (SAFE-LOW) | Cerebral Small Vessel Diseases, Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, granulomatosis with polyangiitis, immune system disorder, interstitial lung disease, lung disorder, microscopic polyangiitis, necrotizing vasculitis, nervous system disorder, respiratory system disorder, skin disorder, skin vascular disease, vascular disorder, vasculitis | Recruiting | Phase 3 | 2026-01-30 | NCT06983821 | |
| Vasculitis Pregnancy Registry | Aortic Arch Syndromes, Behcet disease, Cerebral Small Vessel Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cryoglobulinemic vasculitis, Granuloma, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, Stomatognathic Diseases, Takayasu arteritis, anterior uveitis, anti-neutrophil cytoplasmic antibody-associated vasculitis, aortic disorder, arteritis, autoimmune disease, autoimmune disorder of the nervous system, blood coagulation disease, brain disorder, cardiovascular disorder, central nervous system disorder, central nervous system vasculitis, cerebrovascular disorder, eosinophilic granulomatosis with polyangiitis, eye disorder, granulomatosis with polyangiitis, hematologic disorder, hemorrhagic disease, hereditary disease, hereditary periodic fever syndrome, hereditary skin disorder, immune system disorder, immunoglobulin A vasculitis, interstitial lung disease, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, microscopic polyangiitis, mouth disorder, necrotizing vasculitis, nervous system disorder, panuveitis, polyarteritis nodosa, purpura, respiratory system disorder, skin disorder, skin vascular disease, type III hypersensitivity disease, uveal disorder, uveitis, vascular disorder, vascular hemostatic disease, vasculitis | Recruiting | Not stated | 2026-01-23 | NCT02593565 | |
| Clinical Transcriptomics in Systemic Vasculitis (CUTIS) | Cerebral Small Vessel Diseases, Cryoglobulinemic vasculitis, Granuloma, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, arteritis, autoimmune disease, blood coagulation disease, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, drug-induced vasculitis, eosinophilic granulomatosis with polyangiitis, granulomatosis with polyangiitis, hematologic disorder, hemorrhagic disease, immune system disorder, immunoglobulin A vasculitis, interstitial lung disease, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, microscopic polyangiitis, necrotizing vasculitis, nervous system disorder, polyarteritis nodosa, purpura, respiratory system disorder, skin disorder, skin vascular disease, type III hypersensitivity disease, vascular disorder, vascular hemostatic disease, vasculitis | Recruiting | Not stated | 2026-01-22 | NCT03004326 | |
| VCRC Tissue Repository | Aortic Arch Syndromes, Cerebral Small Vessel Diseases, Granuloma, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, Takayasu arteritis, anti-neutrophil cytoplasmic antibody-associated vasculitis, aortic disorder, aortitis, arteritis, autoimmune disease, autoimmune disorder of the nervous system, blood coagulation disease, brain disorder, cardiovascular disorder, central nervous system disorder, central nervous system vasculitis, cerebrovascular disorder, cutaneous vasculitis, eosinophilic granulomatosis with polyangiitis, granulomatosis with polyangiitis, hematologic disorder, hemorrhagic disease, immune system disorder, immunoglobulin A vasculitis, interstitial lung disease, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, microscopic polyangiitis, necrotizing vasculitis, nervous system disorder, polyarteritis nodosa, purpura, respiratory system disorder, skin disorder, skin vascular disease, temporal arteritis, type III hypersensitivity disease, vascular disorder, vascular hemostatic disease, vasculitis | Recruiting | Not stated | 2026-01-22 | NCT02967068 | |
| One-Time DNA Study for Vasculitis | Aortic Arch Syndromes, Cerebral Small Vessel Diseases, Granuloma, Hemic and Lymphatic Diseases, Skin and Connective Tissue Diseases, Takayasu arteritis, anti-neutrophil cytoplasmic antibody-associated vasculitis, aortic disorder, arteritis, autoimmune disease, autoimmune disorder of the nervous system, brain disorder, cardiovascular disorder, central nervous system disorder, central nervous system vasculitis, cerebrovascular disorder, eosinophilic granulomatosis with polyangiitis, granulomatosis with polyangiitis, immune system disorder, interstitial lung disease, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, microscopic polyangiitis, necrotizing vasculitis, nervous system disorder, polyarteritis nodosa, respiratory system disorder, skin disorder, skin vascular disease, temporal arteritis, vascular disorder, vasculitis | Recruiting | Not stated | 2026-01-22 | NCT01241305 | |
| Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM) | Cerebral Small Vessel Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Skin and Connective Tissue Diseases, Urogenital Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, connective tissue disorder, glomerulonephritis, granulomatosis with polyangiitis, immune system disorder, interstitial lung disease, kidney disorder, lung disorder, lupus erythematosus, lupus nephritis, microscopic polyangiitis, necrotizing vasculitis, nephritis, nervous system disorder, respiratory system disorder, skin disorder, skin vascular disease, systemic lupus erythematosus, urinary system disorder, vascular disorder, vasculitis | Active, not recruiting | Phase 1 | 2025-11-25 | NCT06294236 | |
| An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases | Cerebral Small Vessel Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Granuloma, Hemic and Lymphatic Diseases, IgA glomerulonephritis, Male Urogenital Diseases, Skin and Connective Tissue Diseases, Urogenital Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, connective tissue disorder, eosinophilic granulomatosis with polyangiitis, glomerulonephritis, granulomatosis with polyangiitis, immune system disorder, interstitial lung disease, kidney disorder, lung disorder, lupus nephritis, lymphatic system disorder, lymphoproliferative syndrome, membranous glomerulonephritis, microscopic polyangiitis, necrotizing vasculitis, nephritis, nervous system disorder, respiratory system disorder, skin disorder, skin vascular disease, systemic lupus erythematosus, urinary system disorder, vascular disorder, vasculitis | Active, not recruiting | Phase 1 / Phase 2 | 2025-10-14 | NCT05732402 | |
| Avacopan vs Reduced-dose Glucocorticoids in ANCA-associated Vasculitis | Cerebral Small Vessel Diseases, Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, granulomatosis with polyangiitis, immune system disorder, interstitial lung disease, lung disorder, microscopic polyangiitis, necrotizing vasculitis, nervous system disorder, respiratory system disorder, skin disorder, skin vascular disease, vascular disorder, vasculitis | Recruiting | Phase 4 | 2025-05-04 | NCT06611696 | |
| Special Drug Use-results Survey for Long-term Use（Avacopan） | Cerebral Small Vessel Diseases, Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, granulomatosis with polyangiitis, immune system disorder, interstitial lung disease, lung disorder, microscopic polyangiitis, necrotizing vasculitis, nervous system disorder, respiratory system disorder, skin disorder, skin vascular disease, vascular disorder, vasculitis | Recruiting | Not stated | 2025-01-17 | NCT06758271 | |
| Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE) | Cerebral Small Vessel Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Sjogren syndrome, Skin and Connective Tissue Diseases, Stomatognathic Diseases, Urogenital Diseases, Xerostomia, acquired idiopathic inflammatory myopathy, anti-neutrophil cytoplasmic antibody-associated vasculitis, arthritic joint disease, arthropathy, autoimmune disease, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, connective tissue disorder, dry eye syndrome, eye disorder, glomerulonephritis, granulomatosis with polyangiitis, immune system disorder, interstitial lung disease, kidney disorder, lacrimal apparatus disorder, lung disorder, lupus nephritis, microscopic polyangiitis, mouth disorder, muscle tissue disorder, musculoskeletal system disorder, myositis disease, necrotizing vasculitis, nephritis, nervous system disorder, neuromuscular disease, respiratory system disorder, rheumatic disorder, rheumatoid arthritis, salivary gland disorder, skin disorder, skin vascular disease, systemic lupus erythematosus, systemic sclerosis, urinary system disorder, vascular disorder, vasculitis | Recruiting | Phase 1 / Phase 2 | 2024-10-15 | NCT06350110 | |
| Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases. | Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, arthritic joint disease, arthropathy, autoimmune disease, cardiovascular disorder, connective tissue disorder, granulomatosis with polyangiitis, immune system disorder, interstitial lung disease, lung disorder, musculoskeletal system disorder, necrotizing vasculitis, pemphigus, pemphigus vulgaris, respiratory system disorder, rheumatic disorder, rheumatoid arthritis, skin disorder, skin vascular disease, systemic lupus erythematosus, vascular disorder, vasculitis, vesiculobullous skin disease | Recruiting | Phase 1 | 2024-09-03 | NCT06581562 |